The mechanisms by which DSF combined with Cu reverses cancer drug resistance include the suppression of ALDH, inhibition of NF-κB, activation of the MAPK pathway, inhibition of the ubiquitin-proteasome pathway, and remodeling of the tumor immune microenvironment (Li H. et al., 2020). This evidence concerns the gene NFKB1 and neoplasm.